This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pantarhei Bioscience B.v.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Lung Cancer Treatment by Nafis Ahmed Rahman
Introduction
Nafis Ahmed Rahman is an innovative inventor based in Turku, Finland. He has made significant contributions to the field of cancer treatment, particularly through his research and development of immunotherapeutic methods. His work focuses on harnessing the immune system to combat lung cancer, a disease that affects millions worldwide.
Latest Patents
Nafis Ahmed Rahman holds a patent for an immunotherapeutic method aimed at treating lung cancer. The patent describes a method that involves administering a polypeptide comprising an epitope of hZP3. This invention relates to the treatment and diagnosis of lung cancer and its metastases. The therapeutic use of antigen sources that provide immunogenic polypeptides is central to this innovation. Specifically, the invention utilizes a zona pellucida (ZP) protein, particularly ZP3, to induce a cellular immune response against lung cancer cells. The patent also covers the use of T cells with receptors that bind to MHC-peptide complexes, as well as antibodies that specifically target the immunogenic ZP polypeptide.
Career Highlights
Nafis Ahmed Rahman is associated with Pantarhei Bioscience B.V., where he continues to advance his research in immunotherapy. His work is pivotal in developing new treatment options for lung cancer patients. The innovative approaches he has taken in his research have the potential to change the landscape of cancer treatment.
Collaborations
Nafis Ahmed Rahman collaborates with Herman Jan Tijmen Coelingh Bennink, contributing to the advancement of their shared goals in cancer research. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Nafis Ahmed Rahman's contributions to lung cancer treatment through his patented immunotherapeutic methods highlight the potential of innovative research in medicine. His work not only aims to improve patient outcomes but also represents a significant step forward in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile